| Earnings Per Share [Text Block] |
NOTE 15 (LOSS) EARNINGS PER SHARE
The following table sets forth the reconciliation of numerators and denominators for the basic and diluted (loss) earnings per share computation for the three and six months ended June 30, 2024 and June 30, 2023:
| (in thousands, except per share data) | | Three months ended June 30, | | | Six months ended June 30, | |
| | | 2024 | | | 2023 | | | 2024 | | | 2023 | |
| Numerator: | | | | | | | | | | | | | | | | |
| (Loss) income from continuing operations | | $ | (2,353 | ) | | $ | (1,777 | ) | | $ | (4,468 | ) | | $ | 25,955 | |
| (Less) plus: net (income) loss from continuing operations attributable to noncontrolling interests | | | (177 | ) | | | 227 | | | | (334 | ) | | | 230 | |
| Less: dividends on preferred stock | | | — | | | | (5 | ) | | | — | | | | (74 | ) |
| Numerator used in calculating basic (loss) earnings per share from continuing operations attributable to common shareholders | | $ | (2,530 | ) | | $ | (1,555 | ) | | $ | (4,802 | ) | | $ | 26,111 | |
| Adjustment to add-back dividends on preferred stock | | | — | | | | — | | | | — | | | | 74 | |
| Adjustment for proportionate interest in Ravix and SNS earnings attributable to common stock | | | — | | | | — | | | | — | | | | (91 | ) |
| Numerator used in calculating diluted (loss) earnings per share from continuing operations attributable to common shareholders | | $ | (2,530 | ) | | $ | (1,555 | ) | | $ | (4,802 | ) | | $ | 26,094 | |
| Income (loss) from discontinued operations | | | 167 | | | | 110 | | | | (46 | ) | | | 217 | |
| Numerator used in calculating diluted (loss) earnings per share - net (loss) income attributable to common shareholders | | $ | (2,363 | ) | | $ | (1,445 | ) | | $ | (4,848 | ) | | $ | 26,311 | |
| | | | | | | | | | | | | | | | | |
| Denominator: | | | | | | | | | | | | | | | | |
| Weighted-average basic shares | | | | | | | | | | | | | | | | |
| Weighted-average common shares outstanding | | | 27,309 | | | | 25,295 | | | | 27,223 | | | | 24,681 | |
| Weighted-average diluted shares | | | | | | | | | | | | | | | | |
| Weighted-average common shares outstanding | | | 27,309 | | | | 25,295 | | | | 27,223 | | | | 24,681 | |
| Effect of potentially dilutive securities (a) | | | | | | | | | | | | | | | | |
| Unvested restricted stock awards | | | — | | | | — | | | | — | | | | 812 | |
| Warrants | | | — | | | | — | | | | — | | | | 1,357 | |
| Total weighted-average diluted shares | | | 27,309 | | | | 25,295 | | | | 27,223 | | | | 26,850 | |
| Basic (loss) earnings attributable to common shareholders: | | | | | | | | | | | | | | | | |
| Continuing operations | | $ | (0.09 | ) | | $ | (0.06 | ) | | $ | (0.18 | ) | | $ | 1.06 | |
| Discontinued operations | | $ | 0.01 | | | $ | 0.00 | | | $ | — | | | $ | 0.01 | |
| Basic (loss) earnings per share - net (loss) income attributable to common shareholders: | | $ | (0.08 | ) | | $ | (0.06 | ) | | $ | (0.18 | ) | | $ | 1.07 | |
| Diluted (loss) earnings attributable to common shareholders: | | | | | | | | | | | | | | | | |
| Continuing operations | | $ | (0.09 | ) | | $ | (0.06 | ) | | $ | (0.18 | ) | | $ | 0.97 | |
| Discontinued operations | | $ | 0.01 | | | $ | 0.00 | | | $ | — | | | $ | 0.01 | |
| Diluted (loss) earnings per share - net (loss) income attributable to common shareholders | | $ | (0.08 | ) | | $ | (0.06 | ) | | $ | (0.18 | ) | | $ | 0.98 | |
| | (a) | Potentially dilutive securities consist of unvested restricted stock awards and warrants, calculated using the treasury stock method, and convertible preferred stock, using the if-converted method. Because the Company is reporting a loss from continuing operations attributable to common shareholders for the three and six months ended June 30, 2024 and the three months ended June 30, 2023, all potentially dilutive securities outstanding were excluded from the calculation of diluted loss from continuing operations per share since their inclusion would have been anti-dilutive. |
Basic (loss) earnings per share excludes dilution and is computed by dividing (loss) income attributable to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted (loss) earnings per share is calculated using weighted-average diluted shares. Weighted-average diluted shares is calculated by adding the effect of potentially dilutive securities to weighted-average common shares outstanding. Potentially dilutive securities are excluded from the diluted (loss) earnings per share computation in loss periods and when the applicable exercise price is greater than the market price on the period end date as their effect would be anti-dilutive.
The following weighted-average potentially dilutive securities are
not included in the
dilut
ed
(loss) earnings
per share calculations above because they would have had an antidilutive effect on the
(loss)
earnings
per share:
| | | Three months ended June 30, | | | Six months ended June 30, | |
| | | 2024 | | | 2023 | | | 2024 | | | 2023 | |
| Stock options | | | 265,000 | | | | — | | | | 265,000 | | | | — | |
| Unvested restricted stock awards | | | 548,964 | | | | 1,146,947 | | | | 548,964 | | | | 335,540 | |
| Warrants | | | — | | | | 3,152,795 | | | | — | | | | 1,795,743 | |
| Convertible preferred stock | | | — | | | | — | | | | — | | | | — | |
| Total | | | 813,964 | | | | 4,299,742 | | | | 813,964 | | | | 2,131,283 | |
|